Abiopharma

New Form SC TO-T/A - Cidara Therapeutics, Inc. Filed: 2026-01-07 AccNo: 0001193125-26-005513 Size: 46 KB

Oramed Receives $18 Million Payment from Scilex Holdings, Bringing Current Returns to $118 Million; Board Approves Dividend Payments

Salarius Pharmaceuticals Changes Corporate Name to Decoy Therapeutics and Nasdaq Ticker Symbol to DCOY Reflecting Focus on Next-Generation Peptide Conjugate Therapeutics

Curis Announces Pricing of Private Placement Totaling up to $80.8 Million in Gross Proceeds

Landmark Study Finds PreTRM® Blood Test Reduces Earliest Preterm Births and Newborn Complications

Sensus Healthcare Appoints Larry Biscotti to its Board of Directors

(99% Neutral) PROCESSA PHARMACEUTICALS, INC. (PCSA) Announces Update on Collaboration with PROCESSA PHARMACEUTICALS

(30% Negative) SAB BIOTHERAPEUTICS, INC. (SABSW) Announces Delay in confidence Trials for advancing innov Due to Regulatory Process, Manufacturing Considerations

(99% Neutral) MOLECULIN BIOTECH, INC. (MBRX) Announces Update on Collaboration with MOLECULIN BIOTECH, INC

Inogen Announces the Launch of Aurora CPAP Masks for Obstructive Sleep Apnea in the United States

(30% Negative) Adicet Bio, Inc. (ACET) Announces Delay in data Trials for October from our prula-cel P Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

Sarepta Therapeutics Announces Submission of Clinical Trial Application for SRP-1005, its Investigational Treatment for Huntington’s Disease

Lexicon Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference

GeneDx Announces GenomeDx Prenatal™, Expanding Industry-Leading Genomic Diagnosis Into Prenatal Care

Disc Medicine to Present at the 44th Annual J.P. Morgan Healthcare Conference